Mahalumbay, Florentino L.
HRN: 12-38-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/21/2024
05/28/2024
IV
2.25g
Q6
Septic Shock Secondary To UTI
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes